Article

Vistakon to discontinue Acuvue Toric brand

Jacksonville, FL?The Vistakon division of Johnson & Johnson Vision Care Inc. will discontinue its Acuvue Toric contact lenses as of January.

End in sight

Jacksonville, FL-The Vistakon division of Johnson & Johnson Vision Care Inc. will discontinue its Acuvue Toric contact lenses as of January.

The decision was made, according to Vistakon, because the company's Acuvue Advance for Astigmatism lenses have generated strong sales resulting from design features that make them "a better option for current Acuvue Toric patients," said Pat Cummings, OD, vice president-professional affairs and customer development.

To help patients who have been wearing Acuvue Toric lenses make a smooth transition, Vistakon will offer a $75 rebate following an eye exam and purchase of a 1-year supply of Acuvue Advance for Astigmatism lenses.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.